China develops African swine fever vaccine to curb disease that’s nearly halved its pork production

| March 4, 2020
pigterrine
Credit: Appetite
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

China’s Harbin Veterinary Research Institute, the country’s top research body on animal diseases, said it developed an African swine fever vaccine that laboratory testing has showed is safe and effective.

The institute, which is overseen by the Chinese Academy of Agricultural Sciences, said the live vaccine with reduced virulance was created from a series of gene-deleted viruses using the country’s first African swine fever strain as a backbone.

The disease, which is deadly for pigs but isn’t known to harm humans, first broke out in China in 2018. Since then, hog herds in the world’s top consumer and producer of pork have fallen by nearly half as global researchers looked to develop the world’s first African swine fever vaccine.

Related article:  Conflicting pesticide regulations may fuel needless food safety disputes

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend